About
Combination of existing products
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
12
As Collaborator
0
Total Enrollment
1,625
By Phase
PHASE3: 3PHASE1: 1PHASE2/PHASE3: 2PHASE2: 4PHASE1/PHASE2: 1
By Status
COMPLETED: 5ACTIVE_NOT_RECRUITING: 3RECRUITING: 2UNKNOWN: 1APPROVED_FOR_MARKETING: 1
Clinical Trials Pipeline11 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06747468Lead Sponsor
Avexitide for Treatment of Post-Bariatric Hypoglycemia
PHASE3Recruiting
75 participants
Started: Apr 29, 2025 · Completed: Oct 31, 2026
NCT06665165Lead Sponsor
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
PHASE1Recruiting
48 participants
Started: Apr 7, 2025 · Completed: Oct 31, 2027
NCT06122662Lead Sponsor
AMX0035 and Progressive Supranuclear Palsy
PHASE2/PHASE3Active, not recruiting
110 participants
Started: Dec 21, 2023 · Completed: Nov 30, 2029
NCT05676034Lead Sponsor
AMX0035 in Adult Patients With Wolfram Syndrome
PHASE2Active, not recruiting
12 participants
Started: Mar 3, 2023 · Completed: Dec 31, 2026
NCT05619783Lead Sponsor
Extension Study Evaluating The Safety And Tolerability of AMX0035
PHASE3Completed
352 participants
Started: Dec 29, 2022 · Completed: Oct 30, 2024
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...